Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy-Reference-Cited by-同舟云学术

Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy

Published:2017-10-11 Issue:1 Volume:36 Page:51-57
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Bandini Marco,Smith Ariane,Zaffuto Emanuele,Pompe Raisa S.,Marchioni Michele,Capitanio Umberto,Chun Felix K.,Kapoor Anil B.,Shariat Shahrokh F.,Montorsi Francesco,Briganti Alberto,Karakiewicz Pierre I.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-017-2093-6/fulltext.html

Reference23 articles.

1. Wolff I, May M, Hoschke B et al (2016) Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 42:744–750. doi: 10.1016/j.ejso.2016.01.009

2. Frank I, Blute ML, Cheville JC et al (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168:2395–2400. doi: 10.1097/01.ju.0000035885.91935.d5

3. Ravaud A, Motzer RJ, Pandha HS et al (2016) Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy. N Engl J Med 375:2246–2254. doi: 10.1056/NEJMoa1611406

4. Noone A-M, Cronin KA, Altekruse SF et al (2017) Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 26:632–641. doi: 10.1158/1055-9965.EPI-16-0520

5. Scoll BJ, Wong Y-N, Egleston BL et al (2009) Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol 181:506–511. doi: 10.1016/j.juro.2008.10.026

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of lymphadenectomy during primary surgery for kidney cancer;Current Opinion in Urology;2023-04-10

2. How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?;World Journal of Urology;2022-09-20

3. Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature;Asian Journal of Urology;2022-07

4. Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis;Immunotherapy;2022-06

5. High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?;Current Problems in Cancer;2021-12